Thursday, September 30, 2021

Remember 'Who's on First?

Pearls Before Swine strikes again. How do I love this comic strip, let me count the ways.....For those of us who use WhatsApp, it's simply gold. 




Monday, September 27, 2021

Traveling internationally during the pandemic

My recent trip to New York State during the pandemic showed me that as long as one is fully vaccinated, it is safe to travel internationally. I had originally booked a direct flight to Newark from Oslo on SAS, but that changed to an indirect flight via Copenhagen in order to fill up the plane. There were not enough people in Oslo flying to Newark at the beginning of September. I understood why when I read the US travel restrictions; pretty much only American citizens/green card holders are allowed entry into the USA. The same holds true for Norway and many other European countries; only citizens and permanent residents are allowed entry. When I saw the empty airports in Oslo and when I arrived in Newark, I understood that most people who normally fly to the USA are in fact tourists from other countries, and that the tourism industry in the USA must have suffered big-time during the pandemic. President Biden is considering a proposal to lift the travel bans for non-Americans in November. I hope that will be the case, because I cannot imagine how those Americans who rely on tourism for a living can manage in the long run. Of course I understand that the safety of the country comes first. But now that the majority of people are vaccinated in America and in Europe, it should be safe to lift the travel restrictions. 

I have never gone through passport control in the USA as quickly as I did now, and the same was true for when I returned to Oslo. I think it took less than five minutes at both airports. I had to show my vaccine passport to airline personnel in Oslo before I was allowed to board the plane to Copenhagen, and then again in Copenhagen before I could board the plane for the USA. I also had to have proof of a negative Covid PCR test within 72 hours of traveling to the USA; I traveled on a Monday morning so I took the test on the preceding Friday afternoon. Luckily it was negative, as was the rapid Covid test I had to take in the USA within three to five days after I arrived. On the day I was to board the plane for Oslo, I had to show my vaccine passport in order to board. Norway, unlike the USA, did not require a negative Covid test in order to fly. SAS required that passengers wear masks for the duration of the flights, and although I was nervous about this particular aspect, it worked out fine, much better than I expected. The SAS personnel took good care of us; they deserve praise for good service and help. Keeping track of all the travel requirements was a bit stressful but definitely doable and I was not discouraged from wanting to travel again. 

As luck would have it, the pandemic has 'ended' for all intents and purposes in Norway. By this I mean that all restrictions were lifted as of this past Friday. No more masks, no more social distancing. The young people of Oslo responded to the news by partying wildly the entire weekend; we older folks were happy about the news but did not feel the need to behave like the young people. I was at a small dinner party at an Indian restaurant this past Friday in order to celebrate my PhD student's defence; it was nice to sit together with people again and not worry about keeping a meter's distance between us. The pandemic is not 'over' in the USA, mostly because there are still many unvaccinated people who will end up delaying the reopening of the country. Too bad, because the USA was way out in front when it came to making vaccines available for its people. European countries were slow to make the vaccines available to their citizens, but once they did, the percentage of people who got vaccinated ended up being higher than that in America. 

In any case, regardless of what transpires in the coming months, we will not be returning to lockdown conditions. I think the health officials here have understood that we need to learn to live with the virus and get vaccinated each year against it, just as we live with the different flu viruses that arrive each year and for which we take a vaccine. If it's not worse than this, it's doable. By that I mean a minor inconvenience, one I'm willing to endure in order to be able to live normally and to travel. My attitude is 'do what is necessary in order to make those things happen'. I'm not going to rant and rave about my rights being taken away and all the rest of the nonsense when I have more important goals--being together with those I love in the USA. I'll do whatever it takes to make that happen. 


Wednesday, September 22, 2021

Change and courage





















It does, doesn't it? When you think about it, change is scary. So yes, moving out of your comfort zone requires courage. Here's to all of us who are in that boat, riding the waves of change. The water can sometimes be choppy, and sometimes we don't really know where we're going. But we manage and the waters eventually become calmer. 

Tuesday, September 21, 2021

What I won't miss about working in academic research science

I recently published a post 'What I will miss about working as an academic research scientist' (A New Yorker in Oslo: What I will miss about working as an academic research scientist (paulamdeangelis.blogspot.com). There are some things that I won’t miss about academic research, and now I can write about them. As long as I did academic research I never felt I had the freedom to really write the truth about this arena, at least the arena I've experienced here in Norway.

I won't miss the arrogance and elitism that exist in the academic workplace. Too many research leaders (mostly men but also one or two women) used their leadership positions to disparage other researchers (including PhD students and postdocs who worked for them and for whom they developed a dislike) in an effort to make themselves look much better than they actually were. Several actually thought they were extraordinary researchers, and they were not. Truth be told, they were and are middle-of-the-road researchers with grant funding and a few good papers under their belts, nothing more. They were preoccupied with prestige, power, control, and money. If they had all these things they were automatically better than the others who didn't have these things, and that viewpoint was supported all the way to the top of university hospital leadership. This is probably not ground-breaking news to those who've worked in academia for years. My point in commenting on it is the following: how research leadership behaves and what they allow in terms of bad or questionable behavior sets the tone for the workplace--pleasant and productive, or unpleasant and ultimately unproductive (or unwillingly productive). You cannot have it both ways. Arrogance and elitism do not lead to healthy research production. They lead to demotivation and inertia in those who have to suffer with them; the ones who often suffer most are the scientists in untenured positions. Arrogance and elitism were allowed (or at least not discouraged) in my former workplace, to the detriment of the careers of many younger scientists and colleagues. I know that because the latter often came to my office over the years to get support and to share their feelings of despair and demotivation. Most of them left academia when they were still young enough to start over somewhere else, usually in the private sector where they ended up not only feeling more at home but where they were able to create successful careers. 

I won't miss the conformity/lack of intellectual diversity that characterize a lot of academic workplaces. I could list up several areas, among them immunotherapy, that would guaranteed get you a lot of grant funding, but at what cost? It stands to reason that not everyone can work in this field, and why would they want to? Researchers are at heart an independent bunch; they like to have the intellectual freedom to study what they want (within the guidelines of their institutions, of course). But it is that intellectual freedom that is important, or at least was important. Nowadays you are likely to be told by research leadership that your area of interest is not worth pursuing; you should pursue an area that will net you the most money. I have no problems with their advice or suggestions, but it is very unrealistic to expect that all medical research scientists would want to work in the field of immunotherapy. You don't just snap your fingers and poof--now I know all there is to know about immunotherapy and patient treatment when for years your research interests tended toward basic science (non-patient-related) questions. Conformity and intellectual freedom are a poor match. But since conformity leads to money, and academic research is now big business, it stands to reason that conformity rules. Some of the scientists I most enjoyed talking to and collaborating with were non-conformists (like me) who believed in what they were doing and struggled along. It must be said that up until around 2006, it was still possible to get a basic research project funded. Nowadays it is a rare occurrence.

I won't miss the frequent lack of interest in informing employees of what was going on in the department, in dealing with pressing problems, or in the research that employees were doing. One leader had the habit of shrugging his shoulders whenever problems that needed to be addressed and discussed were brought up. They weren't his problem. 'I really don't care, do you?' That type of attitude, which essentially says to others--F*** off and don't bother me. Even those leaders who did listen did very little about the problems at hand. And just to be clear, there is a big difference between running to a leader with every minute problem versus talking to them about one or two select issues. Very few people did the former. It wouldn't have mattered one way or another; the response would have been the same--lack of interest. It was demoralizing, because nothing ever gets solved with that attitude. 

I won't miss the indecisiveness, procrastination, non-committal leadership, and inertia of academia, the countless meetings about the same problem or issue that could have been solved with clear-cut decisions but rarely were. Some leaders were deathly afraid of making a decision that could turn out down the road to be a mistake, so they didn't make any decisions at all. Fear leads to indecisiveness and procrastination. Indecisiveness and procrastination help no one, and simply contribute to the inertia that a workplace becomes mired in over time. My motto was 'Just do it' (to paraphrase Nike). That doesn't mean that I was impulsive or proactive without good and well-researched reasons for acting. It means that I was ready and able to make a decision and to stick to it after I reviewed the facts. I was not afraid to be wrong, because if your decision proves to be the wrong one you admit that and move on. But if you remain non-committal you won't (ever) make a mistake. But you won't take a risk either, and that is necessary in order for an institution to move forward. For all the incessant talking about change and the necessity for it, there was very little actual change. I discovered that most people simply liked to talk rather than act. That wasn't me. Perhaps I too would have found a better fit in the private sector. 

And finally, I won't miss feeling old. I’m three weeks into retirement and I don’t feel old anymore. The last few years in academia made me feel old—no longer professionally relevant, no longer competitive, no longer in the game. I’ve written about the reasons why in my ‘Publish or languish’ post (A New Yorker in Oslo: Publish or languish (paulamdeangelis.blogspot.com). If you don’t get grant funding, you’re just ‘hanging on in quiet desperation’ until retirement. Some hang on until they’re sixty-seven; others until they’re seventy-two. I was simply not interested in doing either. I retired early. Older scientists are not really respected anymore (if they ever were). I don't know if my viewpoints can be extrapolated to other countries, but I'm guessing that they can (if the limited Netflix series The Chair gives a good indication of what goes on at top universities in the USA these days). In that series, the leadership of the English literature department wants to get rid of its older professors. It doesn’t prove to be an easy task, but it must be rather dismaying to know that your workplace would prefer that you retire or quit. But that’s all part of the game; best not to take it too seriously. Best to leave when the going is good, when you still have your health, when life is still an adventure. Because life is an adventure, and work is not the only thing in life that defines us. The fun part will be discovering and rediscovering the parts of us that have been hidden all these years. I’m looking forward to that.


Sunday, September 19, 2021

My laugh for the day

If you need a good laugh, here are some recent comic strips from two of my favorites--Pearls Before Swine and Non Sequitur: 


Pearls Before Swine by Stephan Pastis




Non Sequitur by Wiley Miller 




Wednesday, September 8, 2021

Publish or languish

"Hanging on in quiet desperation", to paraphrase Pink Floyd. That about sums up remaining in academia as an older scientist (over sixty) in some workplaces and universities. At my former workplace, there were many older scientists who were deemed unproductive by research leadership. That may have been true for one or two older scientists, but by and large the majority of older scientists were just as productive and had just as much motivation to do research, publish, and mentor PhD and Masters students as scientists half their age. But they seldom got the chance because research funding dried up and no matter how relevant they tried to make their grant applications, they were rejected. It often started when they were in their mid- to late-fifties and just continued. My question is why any older scientist in his or her right mind would want to hang around languishing in a workplace that no longer wants them or considers them productive? To languish is to be 'forced to remain in an unpleasant place or situation'. That describes the daily life of many older scientists. Of course I understand that not all cannot retire in their fifties (although I know teachers and civil servants who did just that, with good pensions to support them). 

So what's an older scientist to do in an academic workplace that no longer values him or her? He or she can hang on in quiet desperation and 'hope' for more grant funding after having written grant application after grant application ad nauseam. Good luck with that. 'Hope springs eternal', as Alexander Pope said. Or the older scientist can hope for some good will from research leadership, but I would say don't hold your breath. From what I've seen and heard during the past decade, some of the research leaders did nothing but badmouth the older scientists they deemed unproductive. They disparaged them or poked fun at them; I know because I sat in on some of the leader meetings and was witness to their behavior. Of course not all research leaders were like this. But as karma would have it, one of those types of leaders in my former workplace is now having problems getting funding for his research; he's reached that crucial age when it all changes. And so it goes. Since he was one of those leaders who actively disparaged his peers, I am very glad to hear that he is now having problems of his own. It couldn't happen to a nicer guy as we say in America.

Publish or languish. That is the choice for many older tenured scientists. It becomes a catch-22 situation after a while. If you no longer obtain funding for your research, you cannot attract students nor will you be able to get technical help. You will end up working alone in the lab, and it goes without saying that your research production will slow down, you will publish much less, and that will go a long way toward ensuring that you do not remain in the running for grant funding. And so it goes. No grant funding, no students and no help, thus no publications and no grant funding. 

Do I have ready answers to this problem? I do not. I merely present it. It used to be publish or perish, but nowadays it's publish or languish because so many older scientists hang onto their tenured positions with every ounce of strength they've got. Some who should have more self-insight refuse to acknowledge that their time in the sun is over. For some it's an identity problem; they simply cannot see themselves doing anything else other than research. They've lived and breathed research their entire lives. My advice to academic scientists who are approaching that crucial age when it all changes, is to take a good long hard look around them, around their workplace. See if older scientists are valued or if they are just pushed to the side and ignored. See if there is subtle pressure on them to retire early. Just see how they're treated, because guaranteed, once you reach their age, that is how you yourself will be treated. 

 

Friday, September 3, 2021

Daily outrage as interpreted by Wiley Miller

Non Sequitur by Wiley Miller is one of my favorite comic strips. I thought this comic from a few days ago was rather apt, since the people who need to be outraged on a daily basis get excellent help from the media--newspapers, cable news, television news, online news. Take your pick. 




What I will miss about working as an academic research scientist

This past Monday was my last day as a full-time employee at my university hospital. I can now call myself 'retired'. Not out to pasture 😀, just retired from the job I've been doing for the past thirty years. My department hosted a small and very nice retirement party for me on Monday afternoon; most of the attendees were current and former research group members, department leaders, research technicians, and collaborators. The reactions from co-workers and colleagues to the news of my retirement have been mixed; all of them wish me well, some understand why I'm leaving now, some wonder if I'm retiring too soon and if I will be bored, one woman said right out loud how lucky I was to be retiring. I am glad I decided to retire now. I look forward to a new chapter in my life and to the freedom to put some of my ideas into action. 

There were several talks given about me and my contributions to the department over the years. Those who held the talks were those who have known me the longest. They know what I have accomplished as an academic research scientist. They also know how much help and support I've given others. I was described as having integrity and as someone who believes in fairness/fair play. Those are very true statements; I abhor nepotism, borderline corruption, rewards given to those who do not deserve them. The list is long. I was also described as a driving force by my former boss, who talked about how I brought new techniques into the lab and performed some work (published in 2007) that virtually no one else in the world had done before. Those were nice words to hear. He also described me as someone who can say no, and that is also true; I am not just a yes-person. I have my own opinions and thoughts; I respect what others have to say but if I firmly believe in what I want or in what I think is best for a project or a group, I am hard to dissuade. 

But it is the people I have worked with over the years that I will miss the most. Projects come and go, grant funding came and went, prestige disappears, but what matters the most is how you have treated those who worked for you and with you. It always surprises me how so few people really understand that. People remember how they were treated; I will always remember how well I was treated by the three men (the triumvirate--Frank, Zbigniew and Myron) I worked for at Memorial Sloan-Kettering Cancer Center. My co-workers here in Oslo described me as 'raus'. In English it means 'willing to share and to give a lot, to give without the expectation of anything in return, not miserly'. That was also good to hear, because it's true. I know some leaders who are miserly; by hanging onto their knowledge they hang onto the control they have over others, because it is mostly control and power that they want. God forbid someone under them should 'challenge' their knowledge. But being a miser costs, because misers are not good leaders, and those who work for misers remember their utter selfishness and egoism. I learned 'raushet' from working for others who were 'rause', the men I worked for at Memorial. They gave of their expertise, patience, and knowledge, willingly. They wanted us to succeed. They wanted us to shine. They wanted us to 'outgrow' them. Those are good leaders, and those are the leaders I remember, not the miserly ones, not the rude ones, not the ones who never give of their time willingly. I've met far too many of the latter. 

We scientists would have published very little of our work without the competence and expertise of the research technicians who have worked in our groups over the years. So they are the people I will miss the most. It was a pleasure and a privilege to work with them and to publish articles together. I will miss doing research--the intellectual freedom to pursue an idea and to see where it leads. There is almost nothing that comes close to that feeling of freedom when it all works out. But science the way I enjoyed doing it has changed. I commented on that change in my speech at the end of the party; science is big business now--big money and big research groups. It wasn't always that way, and I prefer the days when research groups were small and money didn't rule. I said that to my audience. Because that is true too. Small is nice. Small allows you to care about the projects and the people involved. I'm grateful for a career that allowed me to do that. 


Out In The Country by Three Dog Night

Out in the Country  by Three Dog Night is one of my favorite songs of all time. When I was in high school and learning how to make short mov...